SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hasdai, D.
Right arrow Articles by Battler, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hasdai, D.
Right arrow Articles by Battler, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Effect of Low Molecular Weight Heparin (Fragmin) on Myocardial Neutrophil Accumulation and Infarct Size in a Rat Model of Myocardial Infarction

David Hasdai

Neufeld Cardiac Research Institute, Sheba Medical Center and Sackler Medical School, Tel Aviv University, Israel

Nira Varda-Bloom

Neufeld Cardiac Research Institute, Sheba Medical Center and Sackler Medical School, Tel Aviv University, Israel

Nehemia Blumberg

Neufeld Cardiac Research Institute, Sheba Medical Center and Sackler Medical School, Tel Aviv University, Israel

Dan Ohad

Neufeld Cardiac Research Institute, Sheba Medical Center and Sackler Medical School, Tel Aviv University, Israel

Ran Kornowski

Neufeld Cardiac Research Institute, Sheba Medical Center and Sackler Medical School, Tel Aviv University, Israel

Alexander Battler

Neufeld Cardiac Research Institute, Sheba Medical Center and Sackler Medical School, Tel Aviv University, Israel

Background: Heparin molecules possess immunomodulating properties, which are thought to complement their established antithrombotic activity. The purpose of this study was to evaluate whether the antiinflammatory properties of low molecular weight heparin (LMWH) can attenuate polymorphonuclear neutrophil accumulation and infarct size in a rat model of myocardial infarction.

Methods: Myocardial infarction was induced by ligating the left main coronary artery. LMWH (fragmin 500 anti-FXa u/kg) or vehicle (saline) were administered subcuta neously thirty minutes prior to coronary artery occlusion. Significant anticoagulant activity was attained with LMWH for more than eight hours. Twenty-four hours later, neutrophil accumulation and infarct size were determined by measuring left ventricular free wall myeloperoxidase and residual creatine kinase activity, respectively.

Results: As compared with rats administered vehicle, myeloperoxidase activity was insignificantly decreased in rats treated with LMWH (1.24 ±0.28 u/g vs 1.66 ±0.15 u/g, P=0.16). Infarct size was also not significantly different between the groups (62.48 ±3.5% and 50.67 ±7.2% of left ventricular free wall with vehicle and LMWH, respec tively, P=0.1).

Conclusion: The authors conclude that LMWH does not significantly reduce myocar dial neutrophil accumulation and infarct size twenty-four hours after myocardial infarc tion in the rat.

Angiology, Vol. 47, No. 5, 491-499 (1996)
DOI: 10.1177/000331979604700508


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement